'Three doses of our vaccine neutralize the Omicron variant' -BioNTech

BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and said they could deliver an upgraded vaccine in March 2022 if needed.